|

| 产地 | 武汉 |
| 品牌 | Chemstan |
| 货号 | CS-18738 |
| 用途 | 科研 |
| 包装规格 | 100 mg |
| 纯度 | 98%% |
| CAS编号 | 5108-96-3 |
| 别名 | 1-Pyrrolidinedithiocarboxylic acid ammonium salt,燗PDC,燩DTC,Ammonium pyrrolidinedithiocarbamate,燩yrrolidinedithiocarbamate |
| 是否进口 | 否 |
| Description |
Pyrrolidinedithiocarbamate ammonium (Ammonium pyrrolidinedithiocarbamate) is a selective NF-κB inhibitor. |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 & Target[1] |
|
||||||||||||||||
| In Vitro |
Pretreatment of cells with Pyrrolidinedithiocarbamate ammonium (Ammonium pyrrolidinedithiocarbamate; 3-1000 μM) dose-dependently attenuate IL-8 production[1] . MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
| In Vivo |
The DSS+pyrrolidinedithiocarbamate ammonium-treated groupII exhibits suppression of shortening of intestinal length and reduction of DAI score. Activated NF-κB level and IL-1β and TNF-α levels are significantly lower in DSS+pyrrolidinedithiocarbamate ammonium-treated groupII. These findings suggest that suppression of NF-κB activity by pyrrolidinedithiocarbamate ammonium can delay the healing of mucosal tissue defects (erosions or ulcers) arising from inflammation, but that it can strongly suppress the expression of inf-lammatory cytokines (IL-1β and TNF-α), resulting in significant alleviation of colitis. pyrrolidinedithiocarbamate ammonium is useful for the treatment of ulcerative colitis[2] . MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
| Molecular Weight |
164.29 |
||||||||||||||||
| Formula |
C?H??N?S? |
||||||||||||||||
| CAS No. |
5108-96-3 |
||||||||||||||||
| 中文名称 |
吡咯烷二硫代甲酸铵盐;四亚甲基二硫代氨基甲酸铵;1-吡咯烷二硫代羧酸铵盐;吡咯烷二硫代氨基甲酸铵;1-吡咯烷硫代羧酸铵盐;吡咯二硫代甲酸铵;四次甲基二硫代氨基甲酸铵;1-吡咯烷羰基二硫酸铵盐 |
||||||||||||||||
| SMILES |
SC(N1CCCC1)=S.N |
||||||||||||||||
| Shipping |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
| Storage |
|
||||||||||||||||
| Solvent & Solubility |
In Vitro:
H2O : 50 mg/mL (304.34 mM; Need ultrasonic) DMSO : ≥ 42 mg/mL (255.65 mM) * "≥" means soluble, but saturation unknown.
Preparing
Stock Solutions
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
In Vivo:
请根据您的实验动物和给药方式 选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*以上所有助溶剂都可在 MCE 网站选购。
|
||||||||||||||||
| References |
|